NCT03925441View on ClinicalTrials.gov

Post-Marketing Surveillance Study of Adalimumab in Pediatric Chronic Severe Plaque Psoriasis Patients in Korea

CompletedOBSERVATIONAL
Enrollment

2

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

August 6, 2019

Study Completion Date

August 6, 2019

Conditions
Psoriasis
Trial Locations (1)

16499

Ajou University Hospital /ID# 207843, Suwon

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY